Contact this trialFirst, we need to learn more about you.
Anti-malarial drug
Hydroxychloroquine + Mesalamine for Ulcerative Colitis
Recruiting1 awardPhase 1 & 2
New York, New York
This trial tests hydroxychloroquine with mesalamine for ulcerative colitis. It focuses on patients of non-European ancestry who still have symptoms despite using mesalamine. Hydroxychloroquine may help by controlling the immune system and reducing inflammation. Mesalamine has a well-established role in the management of ulcerative colitis.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service